Company news

Ryvu Therapeutics SA news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update

May 16, 2024

Ryvu Therapeutics - Expansion of Clinical Development of RVU120 in Low-Risk Myelodysplastic Syndromes

October 23, 2023

Ryvu Therapeutics Provides an Update on the Progress of RVU120 Phase I Studies in Patients with Solid Tumors and AML/HR-MDS, and Presents the Updated Development Plan for RVU120

October 23, 2023

Ryvu Therapeutics Announces Closing of Equity Offering with Gross Proceeds Over PLN 250 Million

December 22, 2022

Ryvu Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 24, 2022

Ryvu Therapeutics Announces Poster Presentations at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Symposium

October 12, 2022

Ryvu Therapeutics Announces Promotion of Hendrik Nogai and Vatnak Vat-Ho to the Management Board

July 26, 2022

Decks

The 5 newest of 7 decks. Every deck is listed under its year.